Guy Cardineau, Ph.D.
Dr. Cardineau began his career in the field of Agricultural Biotechnology in 1983 as a Scientist at a small start-up company, Sungene Technologies, where he also served a short time as Manager of Market Development. He moved to Agrigenetics in 1989 as Manager and then Director of Molecular Biology. In 1993 Agrigenetics was acquired by Mycogen Corporation and Dr. Cardineau assumed responsibility as Director for the merged Molecular Biology groups and eventually for Biochemistry as well.
In 1996 he became Director, Technology Development, involved in strategic planning and implementation regarding Intellectual Property and the identification, evaluation and acquisition of technology directed toward future product development. Dow AgroSciences acquired Mycogen in 1998 and Dr. Cardineau returned to research assuming the positions of Global Leader R&D, Output Agriculture Gene Discovery and Site Leader for the San Diego, CA, Research Facility. In 2002 he became Global Leader for Science and Technology with responsibilities involved in strategic research planning. His efforts, collectively with members of his research team, have resulted in several agricultural biotechnology products in the market place and in commercial development.
He left DAS in the fall of 2002 and co-founded Center for Infectious Diseases and Vaccinology, with Charles Arntzen, Richard Mahoney and Hugh Mason, as part the Center for Infectious Diseases and Vaccinology of the Biodesign Institute at Arizona State University. As of January 1, 2003 he is a Research Professor at ASU with appointments in the Biodesign Institute, the School of Life Sciences and the College of Law.
His academic credentials include an A.B. in American Civilization, a B.S. in Microbiology and a Ph.D. in Molecular and Cellular Biology. He has co-authored numerous scientific papers and has been included in a number of Who’s Who listings as well as Men and Women of Science. He is a member of several scientific societies and also served on the Science Advisory Board for the County of San Diego, CA. He is an inventor of over 40 issued and pending patent applications in the plant sciences, both US and foreign filed, including broad enabling patents describing the earliest production of vaccines in transgenic plants.
Selected Publications
Cardineau G.A., Ellis R.T., Stockhoff B.A., Stamp L., Schnepf H.E., Schwab G.E., Knuth M., Russell J., and Narva K.E. (2002). Novel Bacillus thuringiensis binary insecticidal crystal proteins active on western corn rootworm, Diabrotica virgifera virgifera LeConte. Applied and Enviromental Microbiology 68: 1137-1145.
Cardineau G.A.,Singsit C., Adang M.J., Lynch R.E., Anderson W.F., and Wang A.M., OziasAkins P. (1997). Expression of a Bacillus thuringiensis cryIA(c) gene in transgenic peanut plants and its efficacy against lesser cornstalk borer. Transgenic Research 6: 169-176.
Cardineau G.A.,Stewart C.N., Adang M.J., All J.N., Boerma H.R., Tucker D., and Parrott W.A. (1996). Genetic transformation, recovery, and characterization of fertile soybean transgenic for a synthetic Bacillus thuringiensis crylAc gene. Plant Physiology 112: 121-129.
Cardineau G.A.,Adang M.J., Brody M.S., Eagan N., Roush R.T., Shewmaker C.K., Jones A., Oakes J.V., and McBride K.E. (1993). The reconstruction and expression of a Bacillus thuringiensis cryIlla gene in protoplasts and potato plants. Plant Molecular Biology 21: 1131-1145.
Cardineau G.A., and Curtiss R. (1987). Nucleotide-sequence of the ASD gene of Streptococcus mutans- identification of the promoter region and evidence for attenuator-like sequences preceding the structural gene. Journal of Biological Chemistry 262: 3344-3353.
Cardineau G.A., Murchison H.H., Barrett J.F., and Curtiss R. (1986). Transformation of Streptococcus mutans with chromosomal and shuttle plasmid (PYA629) DNAs. Infection and Immunity 54: 273-282.